Terkko Navigator / -/ Feeds / " ( ( kasvaimen ( ( Lääkeresistenssi )|( Resistenssi )|( Drug Resistance )|( Resistance"

Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation.

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Selective efficacy and safety of first line and non front line antineoplasic agent combinations determined with individualized assays on colorectal cancer primary cultures.

Lactate Induces Cisplatin Resistance in S. cerevisiae through a Rad4p-Dependent Process

KD025, an anti-adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2-overexpressing leukemia cells.

Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer

In vitro and in silico methods to investigate and overcome drug resistance in cancer

A functional genomic screen in Saccharomyces cerevisiae reveals divergent mechanisms of resistance to different alkylphosphocholine chemotherapeutic agents.

Breast Cancer Resistance Protein: A Potential Therapeutic Target for Cancer.

IJMS, Vol. 22, Pages 4955: Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review

Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Cancers, Vol. 13, Pages 2878: Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies

Proteogenomics methods for translational cancer research

Exploring Vulnerabilities in Malignant Glioblastoma

Cutaneous T-cell lymphoma pathogenesis: extracellular vesicles, syncytin-1, and metabolites

High-throughput evaluation of the combinatorial approach to improve NK cell immunotherapy using anti-cancer drugs in acute myeloid leukaemia

INNV-13. SYNERGISTIC EFFECT OF COLD ATMOSPHERIC PLASMA IN COMBINATION WITH TEMOZOLOMIDE TO TREAT GLIOBLASTOMA IN A NON-INVASIVE MOUSE XENOGRAFT MODEL

EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis

Biomolecules, Vol. 10, Pages 1623: New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells

Biomolecules, Vol. 10, Pages 1623: New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells

Cell-free DNA in Non-Small Cell Lung Cancer

Cancers, Vol. 14, Pages 2684: Pancreatic Cancer and Microenvironments: Implications of Anesthesia

IJMS, Vol. 21, Pages 7836: Targeting Autophagy in Breast Cancer

Targeting Autophagy in Breast Cancer.

Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells.

Anticancer natural products with collateral sensitivity: a review.

IJMS, Vol. 22, Pages 10775: Impact of the Pd2Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model

Cells, Vol. 10, Pages 3138: A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors

Cells, Vol. 11, Pages 1211: Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells

Cells, Vol. 11, Pages 1211: Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells

Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes.

Vaccines, Vol. 8, Pages 658: Antitumor Effect of Sugar-Modified Cytosine Nucleosides on Growth of Adult T-Cell Leukemia Cells in Mice

IJMS, Vol. 22, Pages 808: Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia

Biomedicines, Vol. 9, Pages 98: The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma.

Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes

Mycobacterium tuberculosis SIT42 Infection in an Abused Dog in Southern Italy

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

IJMS, Vol. 22, Pages 10920: Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy

Genes, Vol. 13, Pages 330: Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia

Genes, Vol. 13, Pages 330: Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia